Old drugs, new trick: can leukemia meds supercharge cancer immunotherapy?
Disease control
Completed
This study tested if adding two older leukemia drugs (6MP and 6TG) to a modern immunotherapy drug (atezolizumab) could help control advanced solid tumors. The idea was that the older drugs might cause more mutations in the cancer, making it more visible to the immune system. It i…
Phase: PHASE1, PHASE2 • Sponsor: Kristoffer Rohrberg • Aim: Disease control
Last updated Mar 25, 2026 14:07 UTC